This medication is aimed at chronic weight management in adults contending with obesity or being overweight, especially those with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
13.7% | Eli Lilly and Company, accessed April 23, 2025, How to Use, Dosing & Side Effects | Mounjaro (tirzepatide) - Eli Lilly, accessed April 23, 2025, Mounjaro (tirzepatide) Injection: The First and Only GIP and GLP-1 Receptor Agonist Approved for Type 2 Diabetes | Eli Lilly and Company, accessed April 23, 2025, Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight, accessed April 23, 2025, Why you're not losing weight on Zepbound
However, anecdotal reports from patients and online communities suggest that some individuals do experience this symptom, particularly those achieving substantial weight loss
The principles matter more than specific recipes
The purity seems top tier based on my initial findings, performing exactly as expected for my metabolic study
But its not a miracle drug
